Key result
Implementation of European Society of Cardiology guidelines for acute coronary syndrome is frequently suboptimal, necessitating practice-oriented updates to incorporate new data from large trials.
This review highlights the gaps between ESC guidelines for acute coronary syndrome and clinical practice, proposing solutions for better implementation.
Persistent ACS guideline gaps may warrant local audits; leaves open optimal updates incorporating recent trial data.
The management of acute coronary syndrome in Europe is covered by various European Society of Cardiology guidelines, which although valuable, are complex and may not always provide clear guidance in everyday clinical practice. Consequently, implementation of the guideline recommendations is frequently suboptimal. To complicate matters further, a wealth of new data from large trials examining novel anti-thrombotic agents will become or are already available, necessitating guideline updates. This article summarizes the gaps between current guideline-recommended treatment of acute coronary syndrome and daily practice as dictated by the evidence base, including recent trials. Reasons for the suboptimal implementation of the current European Society of Cardiology guidelines and possible solutions to making these more practice oriented are presented.
No takes yet. Share an insight, caveat, or question.
Werf et al. (2012) conducted a review in Acute coronary syndrome. Guideline-recommended treatment was evaluated. Implementation of European Society of Cardiology guidelines for acute coronary syndrome is frequently suboptimal, necessitating practice-oriented updates to incorporate new data from large trials.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: